The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis
- 25 April 2023
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (5) , 1-9
Abstract
Background During chemotherapy for multiple myeloma, symptoms include those related to the disease, as well as adverse effects of the treatment. Few studies have explored the relationships between these symptoms. Network analysis could identify the core symptom in the symptom network. Objective The aim of this study was to explore the core symptom in multiple myeloma patients undergoing chemotherapy. Methods This was a cross-sectional study in which sequential sampling was used to recruit 177 participants from Hunan, China. Demographic and clinical characteristics were surveyed using a self-developed instrument. The symptoms of chemotherapy-treated multiple myeloma, including pain, fatigue, worry, nausea, and vomiting, were measured using a questionnaire with good reliability and validity. The mean ± SD, frequency, and percentages were used as descriptive statistics. Network analysis was used to estimate the correlation between symptoms. Results The results showed that 70% of multiple myeloma patients using chemotherapy exhibited pain. In the network analysis, worrying was the dominant symptom, and the strongest relationship was between nausea and vomiting in chemotherapy-treated multiple myeloma patients’ symptoms. Conclusion Worrying is the core symptom of multiple myeloma patients. Interventions could be most effective if there is a symptom management focus on worrying when providing care to chemotherapy-treated multiple myeloma patients. Nausea combined with vomiting could be better managed, which would decrease the cost of health care. Understanding the relationship between the symptoms of multiple myeloma patients undergoing chemotherapy is beneficial for precise symptom management. Implications for practice Nurses and health care teams should be a priority to intervene in the worrying for chemotherapy-treated multiple myeloma patients to maximize the effectiveness of an intervention. Except, nausea and vomiting should be managed together in a clinical setting.Keywords
This publication has 54 references indexed in Scilit:
- Network Analysis: An Integrative Approach to the Structure of PsychopathologyAnnual Review of Clinical Psychology, 2013
- Gastrointestinal Symptom Representation in Cancer Symptom Clusters: A Synthesis of the LiteratureOncology Nursing Forum, 2012
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continuesThe Lancet Oncology, 2010
- Comorbidity: A network perspectiveBehavioral and Brain Sciences, 2010
- Measuring the Symptom Experience of Chinese Cancer Patients: A Validation of the Chinese Version of the Memorial Symptom Assessment ScaleJournal of Pain and Symptom Management, 2009
- An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaEuropean Journal of Cancer, 2007
- Parents' attitudes towards hepatitis B vaccination for their children. A survey comparing paper and web questionnaires, Sweden 2005BMC Public Health, 2007
- Incidence of multiple myeloma in Olmsted County, MinnesotaCancer, 2005
- Symptoms Experience: A Concept AnalysisOncology Nursing Forum, 2003
- The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEuropean Journal of Cancer, 1994